ILiAD Biotechnologies
2012
FOUNDED
PRIVATE
STATUS
Later Stage VC
LATEST DEAL TYPE
(In Progress)
$3.4M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Owner and operator of a biotechnology company intended to prevent and offer treatment of human disease caused by Bordetella pertussis. The company's services mainly focus on offering treatment for Alzheimer's disease, allergic disease, autoimmune disease and is focused on producing a live attenuated pertussis vaccine, enabling clients to eradicate whooping cough by developing an improved pertussis vaccine.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- 4581 Weston Road
- Suite 260
- Weston, FL 33331
- United States
+1 (917) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore ILiAD Biotechnologies’s full profile, request a free trial.
ILiAD Biotechnologies Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 20-Nov-2019 | $3.4M | 000.00 | In Progress | Clinical Trials - Phase 2 | |
| 6. Later Stage VC (Series C) | 19-Dec-2018 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 5. Angel (individual) | 07-Feb-2018 | 00000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 4. Angel (individual) | 13-Apr-2017 | 000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 3. Angel (individual) | 13-Nov-2015 | 00000 | 00.000 | Completed | Clinical Trials - Phase 1 | |
| 2. Grant | $10M | $3.81M | Completed | Clinical Trials - Phase 1 | ||
| 1. Angel (individual) | $3.81M | $3.81M | Completed | Clinical Trials - Phase 1 |
ILiAD Biotechnologies Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| JEMS venture capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Network-1 Technologies | Corporation | Minority | 000 0000 | 000000 0 | ||
| SDS Capital | Hedge Fund | Minority | 000 0000 | 000000 0 | ||
| Seedlings Life Science Ventures | Corporation | Minority | 000 0000 | 000000 0 | ||
| European Union | Government | 000 0000 | 000000 0 |
ILiAD Biotechnologies Executive Team (4)
ILiAD Biotechnologies Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ariel Pablos-Mendez MD | ILiAD Biotechnologies | Board Member | 000 0000 | |
| Bin Yan Ph.D | ILiAD Biotechnologies | Board Member | 000 0000 | |
| Corey Horowitz | Network-1 Technologies | Board Member | 000 0000 | |
| Cuong Do | ILiAD Biotechnologies | Board Member | 000 0000 | |
| Keith Rubin MD | ILiAD Biotechnologies | Founder, Chief Executive Officer & Board Member | 000 0000 |